TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $4.86B2017: $5.87B2018: $5.15B2019: $6.56B2020: $8.50B2021: $16.07B2022: $12.17B2023: $13.12B2024: $14.20B2025: $14.34B$14.34B
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$14.34B+1.0%
2024$14.20B+8.3%
2023$13.12B+7.8%
2022$12.17B-24.3%
2021$16.07B+89.1%
2020$8.50B+29.6%
2019$6.56B+27.4%
2018$5.15B-12.4%
2017$5.87B+20.8%
2016$4.86B—